NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Boomerang Medical

Boomerang Medical

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://www.boomerangmedical.com/

Last Round

Series B

Sep 4, 2025

Est. Valuation

$75M

Total Funding Raised

$38M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Boomerang Medical is a bioelectronic medicine company developing neuromodulation technology to treat autoimmune diseases, with an initial focus on inflammatory bowel disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neuromodulationbioelectronic medicineimplantable deviceinflammatory bowel diseaseIBDulcerative colitismedtechnerve stimulationclinical trialsFDA breakthrough deviceautoimmune disease treatmentnon-pharmaceutical therapybioelectronicsgastroenterologymedical device startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Boomerang Medical Comps

Public and private peers based on sector, stage, and business model.

Boomerang Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Boomerang Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 4, 2025
Series ANov 1, 2022
SeedOct 18, 2021

Key People

Founding team and executive leadership

David Miller

Chief Technology And Innovation Officer, Co-founder

Founding Team

Heather Simonsen

Chief Executive Officer Board Member

Executive Team

Boomerang Medical Investors

Notable investors and investment history

Boomerang Medical investors
InvestorRounds
Arboretum VenturesSeries A, Series B, Seed
Hatteras Venture PartnersSeries A, Series B
Fogarty InnovationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 4, 2025

    $20M round completed.

  • Nov 1, 2022

    $15M round led by Arboretum Ventures and Hatteras Venture Partners.

Boomerang Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Boomerang Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Boomerang Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMountain View, California
Employee Range17
Year Founded2021
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.